Parallel Advisors, LLC
- SEC CIK
- 0001690010
- Latest filing
- Aug 5, 2026
EFTR holding history
eFFECTOR Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EFTR overviewAll 13F holders of EFTRFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −67,738−100.0% | Sold out | Holders |
| Q2 2024 | 67,738 | $19.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 67,738 | $974.8K | <0.1% | 00.0% | UnchangedConverted for a 1-for-25 split | Holders |
| Q4 2023 | 1,693,559 | $791.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,693,559 | $1.02M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,693,559 | $1.41M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,693,559 | $597.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,693,559 | $724.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,693,559 | $969.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,693,559 | $2.40M | 0.1% | +1,016,107+150.0% | Added | Holders |
| Q1 2022 | 677,452 | $2.74M | 0.1% | +677,452 | New | Holders |